Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

India flag India · Delayed Price · Currency is INR
21.41
-0.22 (-1.02%)
At close: Aug 8, 2025
-1.02%
Market Cap924.48M
Revenue (ttm)76.50M
Net Income (ttm)-184.83M
Shares Out43.18M
EPS (ttm)-4.28
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume15,364
Average Volume39,423
Open21.26
Previous Close21.63
Day's Range21.11 - 22.00
52-Week Range19.00 - 35.88
Beta1.05
RSI26.24
Earnings DateJul 31, 2025

About BOM:524663

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524663
Full Company Profile

Financial Performance

In 2022, BOM:524663's revenue was 446.09 million, a decrease of -43.09% compared to the previous year's 783.88 million. Losses were -166.39 million, 90.1% more than in 2021.

Financial Statements

News

There is no news available yet.